Selected article for: "antibody response and low response"

Author: Otomaru, Hirono; Kamigaki, Taro; Tamaki, Raita; Okamoto, Michiko; Alday, Portia Parian; Tan, Alvin Gue; Manalo, Joanna Ina; Segubre-Mercado, Edelwisa; Inobaya, Marianette Tawat; Tallo, Veronica; Lupisan, Socorro; Oshitani, Hitoshi
Title: Transmission of Respiratory Syncytial Virus Among Children Under 5 Years in Households of Rural Communities, the Philippines
  • Document date: 2019_3_11
  • ID: 0jfvik7w_1
    Snippet: The RSV infection incidence is generally high in young infants (<6 months old) [4] , who are prone to severe diseases due to physical and immunological immaturity [5] . However, because the neutralizing antibody response is low in young infants, vaccines that mimic natural infection may be ineffective if administered to infants before they reach 4 months of age [6] . Maternal antibodies are associated with a lower risk of infection in infants whe.....
    Document: The RSV infection incidence is generally high in young infants (<6 months old) [4] , who are prone to severe diseases due to physical and immunological immaturity [5] . However, because the neutralizing antibody response is low in young infants, vaccines that mimic natural infection may be ineffective if administered to infants before they reach 4 months of age [6] . Maternal antibodies are associated with a lower risk of infection in infants when antibody titers are maintained above the level considered protective during early infancy [7] [8] [9] . Therefore, an alternative vaccination strategy would be to transfer high concentrations of RSV-specific antibody via maternal vaccination, which could provide protection to infants up to 6 months of age, and to combine this approach with active vaccination in infants [10] .

    Search related documents:
    Co phrase search for related documents
    • active vaccination and low risk: 1, 2, 3
    • active vaccination and maternal vaccination: 1, 2, 3
    • active vaccination and natural infection: 1
    • active vaccination and protection provide: 1, 2, 3
    • active vaccination and severe disease: 1, 2, 3
    • active vaccination and vaccination strategy: 1, 2, 3, 4, 5
    • alternative vaccination strategy and antibody response: 1
    • alternative vaccination strategy and vaccination strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • antibody response and early infancy: 1
    • antibody response and high concentration: 1, 2, 3
    • antibody response and infant infection: 1, 2
    • antibody response and infection incidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antibody response and low risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • antibody response and maternal antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • antibody response and maternal vaccination: 1, 2, 3, 4, 5, 6, 7
    • antibody response and natural infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • antibody response and neutralize antibody response: 1, 2, 3, 4, 5, 6
    • antibody response and protection provide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • antibody response and rsv specific antibody: 1, 2, 3, 4, 5